menu search

Evelo Biosciences Provides Clinical and Business Updates

Evelo Biosciences Provides Clinical and Business Updates
– Data from first three cohorts of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint; unusually high placebo response rate observed –– Clear path to registration trials for EDP1815 in psoriasis based on recently completed interactions with FDA, EMA and MHRA –– Dosing commenced in clinical study with first extracellular vesicle […] The post Evelo Biosciences Provides Clinical and Business Updates appeared first on ForexTV... Read More
Posted: Feb 1 2023, 12:30
Author Name: forextv
Views: 102293

Search within

Pages Search Results: